Shed Review

What Shed charges

• NAD+: $144/mo — "NAD+ Nasal Spray / Starting at $144/month / Nasal method / Taken daily / 1 month supply"; the same block prices two other preparations of the same compound at "NAD+ Injections / Starting at $169/month" and "Oral NAD+ Tablets / Starting at $169/month"
• Glutathione: $119/mo — "Glutathione Injections / Starting at $119/month / Injectable method / Taken twice weekly / 1 month supply"
• Sermorelin: $199/mo — the pricing block reads "Injections / Sermorelin / $199/month / Taken 5 times weekly / 1-month supply"; the "$149" elsewhere on the same page is a Wegovy Pill comparison figure, not this compound’s
• GHK-Cu: $279 — the pricing block reads "Billed quarterly / GHK-Cu Scalp Peptide Solution / Starting at $93/month / 3-month supply / $279 for 90 day supply / Applied daily". $279 is the billed figure; the seller separately prints "$93/month" (exactly $279 divided by three) and, in the hero, "Starting at $76.33/month*" with "*3-month commitment required"

Four compounds, each with its supply period stated

The longevity catalog prices four compounds this site tracks, and each product page repeats the figure inside a pricing block that also states the delivery method, the dosing frequency and the supply period.

Stating the supply period beside the figure is the single most useful thing a seller can do here, because it is the fact that makes two sellers comparable at all.

One of the four is priced in three different preparations at two different figures, and all three are recorded rather than flattened into one, so the row cannot be read as one price covering every form.

The compound with the widest catalogue presence is also the one with the most inconsistent pricing, which is covered below.

Three figures for one product, two of them divisions

The copper-peptide product carries a figure in its hero with an asterisk, a different figure on a card elsewhere on the site, and a third arrangement inside its pricing block.

The pricing block is the one that names a billing cycle and a supply period, and it prints both a quarterly total and a per-month figure that is that total divided by three exactly.

The hero's figure divides into a different quarterly total, one the page never prints anywhere.

This row stores the billed quarterly figure and keeps both divisions in the qualifier, because storing either division would publish a number nobody is charged and would rank this seller against others on arithmetic rather than on price.

A weight-loss price sitting on a peptide page

The sermorelin page carries a comparison table for two branded weight-loss products, each with its own starting figure.

One of those figures is lower than the sermorelin price and appears above it in the page's reading order.

Any process that took the lowest figure on the page, or the first, would publish a weight-loss drug's price as this peptide's.

The figure recorded here came from the pricing block that names the compound, the dosing frequency and the supply period, which is the only block on the page that describes what is actually being sold.

The company is named; the pharmacy and the states are not

The terms name the operating company, give a street address and name the state whose law governs, which is a more complete answer than most sellers here give.

The compounding arrangements are described as accredited United States pharmacies and as a licensed pharmacy, without a facility name in either phrasing.

Neither the product pages nor the terms make any claim about which states are served, so this row stores none and asserts nothing about the footprint.

Nothing on any page read describes lab work as part of what is charged, so that flag is false on absence rather than on a denial.

How we verified this

• Rendered the longevity catalog and each product page in a browser and read every figure as laid-out text.
• Took each figure from the element that also contains its own product name, rather than from line proximity, because the card layout puts each figure next to the following product's name.
• Read the copper-peptide pricing block in full and found a quarterly total, a per-month division of it, and a second per-month figure implying a total the page never prints.
• Stored the billed quarterly figure for that product and kept both divisions in the qualifier, so neither can later be mistaken for the price.
• Confirmed by arithmetic that the pricing block's per-month figure is exactly the quarterly total divided by three, and that the hero's figure is not.
• Identified the lower figure on the sermorelin page as a branded weight-loss comparison price and took the compound's figure from the pricing block that names it instead.
• Recorded all three preparations of the multi-form compound with their separate figures rather than storing one rate for every form.
• Fired two nonsense paths at this host in the same pass, one under the products directory, and confirmed both render the same genuine not-found document.
• Read the terms for the operating company, its street address and its governing law, and swept the same document and the product pages for any statement about states, finding none.
• Screened this seller in the live federal warning-letter record using its operating company name rather than its brand, because the brand is a common English word that would over-match, with a known-good positive control and a nonsense negative control fired in the same run.